Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/26CA stock hub

FRA/26CA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/26CAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

7.6B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/26CA

In the news

Latest news · FRA/26CA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-67

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/26CA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

163

Groups with data

Currency

USD

Showing 163 of 163 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	691
Employees Change	11%
Employees Change Percent	1.62
Enterprise value	EUR 8.2B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 7.6B
Price	EUR 7.17
Price currency	EUR
Rev Per Employee	177,717.08x
Sic	2836
Symbol	fra/26CA
Website	https://immunitybio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-9.79%
EV Earnings	-11.07x
EV/FCF	-31.65x
EV/Sales	68.5x
FCF yield	-3.42%
P/B ratio	-10.05x
P/S ratio	61.93x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-185.41%
EBITDA Margin	-174.08%
Gross margin	99.34%
Gross Profit	EUR 121.5M
Gross Profit Growth	349.38%
Gross Profit Growth Q	167.14%
Gross Profit Growth3 Y	520.57%
Gross Profit Growth5 Y	199.72%
Net Income	EUR -741.1M
Pretax Margin	-606.12%
Profit Per Employee	EUR -1.1M
ROA	-34.38
Roa5y	-49.39
ROCE	-45.17
ROIC	-67.01

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	333.93%
Cagr3y	12.39%
Cagr5y	-12.04%
Revenue Growth	351.53x
Revenue Growth Q	167.64x
Revenue Growth3 Y	521.94x
Revenue Growth5 Y	200.12x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.3
Assets	EUR 560.8M
Cash	EUR 330.3M
Current Assets	EUR 384.1M
Current Liabilities	EUR 57.6M
Debt	EUR 975.4M
Debt FCF	EUR -3.76
Equity	EUR -753.8M
Interest Coverage	-2.33
Liabilities	EUR 1.3B
Long Term Assets	EUR 176.7M
Long Term Liabilities	EUR 1.3B
Net Cash	EUR -645M
Net Cash By Market Cap	EUR -8.52
Tangible Book Value	EUR -765.7M
Tangible Book Value Per Share	EUR -0.73

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.67
Inventory Turnover	0.21
Net Working Capital	EUR 11M
Quick ratio	6.24
Working Capital	EUR 333.9M
Working Capital Turnover	EUR 0.55

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-29.76%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	333.5%
200-day SMA	3.77
3Y total return	41.98%
50-day SMA	6.85
50-day SMA vs 200-day SMA	50over200
5Y total return	-47.34%
All Time High	32.75
All Time High Change	-78.1%
All Time High Date	2021-03-23
All Time Low	1.13
All Time Low Change	534.51%
All Time Low Date	2023-03-10
ATR	0.49
Ch YTD	320.5
High	7.19
High52	10.4
High52 Date	2026-02-25
High52ch	-31.06%
Low	6.45
Low52	1.67
Low52 Date	2025-05-08
Low52ch	329.6%
Ma50ch	4.61%
Price vs 200-day SMA	90.08%
RSI	57.53
RSI Monthly	61.28
RSI Weekly	66.19
Sharpe ratio	1.7x
Sortino ratio	3.4
Total Return	-29.76%
Tr YTD	320.7
Tr1m	22.36%
Tr1w	13.27%
Tr3m	40.98%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -226.7M
Operating margin	-185.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	394,033,585%
Net Borrowing	64,363,707.6
Shares Insiders	28.24%
Shares Institutions	17.43%
Shares Qo Q	3.76%
Shares Yo Y	29.76%
Short Ratio	5.47

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -290M
Average Volume	1,075.5x
Bv Per Share	-0.72
CAPEX	EUR -3.9M
Ch1m	22.36
Ch1w	13.27
Ch1y	333.5
Ch3m	40.98
Ch3y	41.98
Ch5y	-47.34
Ch6m	294.8
Change	9.3%
Change From Open	10.82
Close	6.56
Days Gap	-1.37
Depreciation Amortization	13,547,040.9
Dollar Volume	14,124.9
Earnings Date	2026-08-07
EBIT	EUR -226.7M
EBITDA	EUR -212.8M
EPS	EUR -0.77
F Score	3
FCF	EUR -259.2M
FCF EV Yield	-3.16x
Financing CF	542,191,728
Fiscal Year End	December
Goodwill	771,645.4
Income Tax	EUR 93,668
Investing CF	-160,953,534
Is Primary Listing	0
Last Earnings Date	2026-03-02
Last Report Date	2026-03-31
Ma150	4.32
Ma150ch	66.13%
Ma20	6.47
Ma20ch	10.82%
Net CF	126,041,240
Next Earnings Date	2026-08-07
Open	6.47
Position In Range	97.3
Ppne	123,866,049.2
Price Date	2026-05-08
Relative Volume	1.86x
Revenue	122,269,352x
SBC By Revenue	25.14x
Share Based Comp	30,737,979
Tax By Revenue	0.08x
Tr6m	294.93%
Volume	1,970
Z Score	-8.48

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/26CA pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/26CA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/26CA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+17.4%

Share of float held by funds and institutions

Insider ownership

+28.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/26CA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

57.5

Neutral momentum band

Price vs 200-day MA

+90.1%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.70

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/26CA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/26CA stock rating?

fra/26CA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/26CA analysis?

The full report lives at /stocks/fra/26CA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/26CA?

The latest report frames fra/26CA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/26CA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.